Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 844470-82-2 | MDL No. : | MFCD22371843 |
Formula : | C10H13ClFN | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZERUEQOFZLOJJX-PPHPATTJSA-N |
M.W : | 201.67 | Pubchem ID : | 53484769 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 53.35 |
TPSA : | 26.02 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.78 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.46 |
Log Po/w (WLOGP) : | 3.07 |
Log Po/w (MLOGP) : | 2.8 |
Log Po/w (SILICOS-IT) : | 2.61 |
Consensus Log Po/w : | 2.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.85 |
Solubility : | 0.285 mg/ml ; 0.00141 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.65 |
Solubility : | 0.451 mg/ml ; 0.00224 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.96 |
Solubility : | 0.223 mg/ml ; 0.0011 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0 - 24℃; | The title compound was synthesized according to General Method A utili?3-iodo-lH-indazole-5-carboxylic acid (358 mg, 1.23 mmol), (S)- cyclopropyl(2-fluorophenyl) methanamine hydrochloride (250 mg, 1.23 mmol), BOP-C1 (576 mg, 1.3 mmol), DIPEA (1.08 mL, 6.19 mmol) and DMF (5 mL) at 0C. The reaction was stirred and slowly warmed to rt and stirred at 24C for 3 h. The reaction was concentrated and purified by flash chromatography (Biotage isolera 60 g C 18-HS , 5-90% MeOH in 0.1% TFA.H20) to give the title compound as an off white solid (405 mg, 75%). ? NMR (400 MHz, CD3OD) delta ppm 8.08 (s, 1 H), 7.95 (dd, J=8.8, 1.6 Hz, 1 H), 7.56-7.58 (m, 2 H), 7.26-7.31 (m, 1 H), 7.17 (t, J=7.6 Hz, 1 H), 7.09 (t, J=10 Hz, 1 H), 4.76 (d, J=9.2 Hz, 1 H), 1.41-1.50 (m, 1 H), 0.66-0.72 (m, 1 H), 0.58-0.62 (m, 1 H), 0.50-0.56 (m, 2 H); MS ESI 436.2 [M + H]+, calcd for[C18Hl5FP 30+H]+ 436. |
75% | With bis-(2-oxo-3-oxazolidinyl)phosphoryl chloride; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 0 - 24℃; for 3.0h; | Synthesis of (S)-N-(cvcloprovyl(2-fluorophenyl)methyl)-3-iodo-lH-indazole-5-carboxamide The title compound was synthesized according to General Method A utilizing 3- iodo-lH-indazole-5-carboxylic acid (358 mg, 1.23 mmol), (S)-cyclopropyl(2- fluorophenyl) methanamine hydrochloride (250 mg, 1.23 mmol), BOP-C1 (576 mg, 1.3 mmol), DIPEA (1.08 mL, 6.19 mmol) and DMF (5 mL) at 0C. The reaction was stirred and slowly warmed to rt and stirred at 24C for 3 h. The reaction was concentrated and purified by flash chromatography (Biotage isolera 60 g C18-HS . 5-90% MeOH in 0.1% TFA.H20) to give the title compound as an off white solid (405 mg, 75%). NMR (400 MHz, CD3OD) 8 ppm 8.08 (s, 1 H), 7.95 (dd, .7=8.8, 1.6 Hz, 1 H), 7.56-7.58 (m, 2 H), 7.26-7.31 (m, 1 H), 7.17 (t, .7=7.6 Hz, 1 H), 7.09 (t, J=10 Hz, 1 H), 4.76 (d, .7=9.2 Hz, 1 H), 1.41-1.50 (m, 1 H), 0.66-0.72 (m, 1 H), 0.58-0.62 (m, 1 H), 0.50-0.56 (m, 2 H); MS ESI 436.2 [M + H]+, calcd for [C18H,5FrN30+H]+ 436. |
[ 886366-50-3 ]
1-(2-Fluorophenyl)cyclopropanamine
Similarity: 0.92
[ 2061996-47-0 ]
(S)-7-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.92
[ 2061980-60-5 ]
4,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.92
[ 1955554-65-0 ]
1-(2-Fluorophenyl)propan-1-amine hydrochloride
Similarity: 0.91
[ 1310923-28-4 ]
(S)-1-(2-Fluorophenyl)propan-1-amine hydrochloride
Similarity: 0.91
[ 886366-50-3 ]
1-(2-Fluorophenyl)cyclopropanamine
Similarity: 0.92
[ 2061996-47-0 ]
(S)-7-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.92
[ 2061980-60-5 ]
4,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.92
[ 1955554-65-0 ]
1-(2-Fluorophenyl)propan-1-amine hydrochloride
Similarity: 0.91
[ 1310923-28-4 ]
(S)-1-(2-Fluorophenyl)propan-1-amine hydrochloride
Similarity: 0.91
[ 886366-50-3 ]
1-(2-Fluorophenyl)cyclopropanamine
Similarity: 0.92
[ 2061996-47-0 ]
(S)-7-Fluoro-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.92
[ 2061980-60-5 ]
4,7-Difluoro-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.92
[ 1955554-65-0 ]
1-(2-Fluorophenyl)propan-1-amine hydrochloride
Similarity: 0.91
[ 1310923-28-4 ]
(S)-1-(2-Fluorophenyl)propan-1-amine hydrochloride
Similarity: 0.91